Tune Therapeutics
Tune Therapeutics raises $175M Growth
Quick Facts
Tune Therapeutics: Growth Funding Round
Tune Therapeutics has successfully raised $175M in Growth funding.
Company Overview
Epigenetic programming startup developing therapies for chronic conditions
Funding Details
The Growth round was led by Hevolution, with participation from New Enterprise Associates, Regeneron Ventures, Yosemite.
Company Information
- Headquarters: Durham, NC
- Founded: 2020
- Employees: 150+
- Category: HealthTech
Investment
Tune Therapeutics plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Hevolution: Verified investor in Growth
- New Enterprise Associates: Verified investor in Growth
- Regeneron Ventures: Verified investor in Growth
- Yosemite: Verified investor in Growth
Key Investors
About the Author
Related Company Reports
Abridge Raises $150M Series C to Transform HealthTech
Abridge has secured $150M Series C in funding to accelerate growth and innovation in the healthtech sector. Medical AI scribe platform automatically documenting patient-provider conversations and generating clinical notes...
Innovaccer Raises $275M Series F to Transform HealthTech
Innovaccer has secured $275M Series F in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform unifying patient data and providing analytics for value-based care and population health manage...
Truveta Raises $95M Series B to Transform HealthTech
Truveta has secured $95M Series B in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform aggregating de-identified patient records to accelerate medical research and drug development...
